European Neurology
Original Paper
Neuroprotein Dynamics in the Cerebrospinal Fluid: Intraindividual Concomitant Ventricular and Lumbar MeasurementsBrandner S.a · Thaler C.a · Lewczuk P.b · Lelental N.b · Buchfelder M.a · Kleindienst A.aDepartments of aNeurosurgery, and bPsychiatry and Psychotherapy, University of Erlangen-Nürnberg, Erlangen, Germany
|
|
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
Article / Publication Details
Received: March 27, 2013
Accepted: May 05, 2013
Published online: August 17, 2013
Issue release date: October 2013
Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 1
ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)
For additional information: https://www.karger.com/ENE
Abstract
Objective: The measurement of neuromarker/neuroproteins in the cerebrospinal fluid (CSF) is gaining increased popularity. However, insufficient information is available on the rostrocaudal distribution of neuroproteins in the CSF to guarantee an appropriate interpretation of ventricular versus lumbar concentrations. Methods: In 10 patients treated with both an external ventricular and a lumbar CSF drain, we collected concomitant CSF samples. We measured CSF concentrations of the glial S100B protein, the neuron-specific enolase (Cobas e411®; Roche Diagnostics), the leptomeningeal β-trace protein (BN Pro Spec®; Dade Behring/Siemens), and the blood-derived albumin (Immage; Beckman Coulter). Statistical analysis was performed with a paired Wilcoxon signed ranks test. Results: In patients with a free CSF circulation without any recent neurosurgical procedure, S100B and neuron-specific enolase concentrations did not differ between the ventricular and lumbar CSF while β-trace and albumin levels were significantly higher in the lumbar than in the ventricular CSF (p = 0.008 and p = 0.005). Following posterior fossa tumor surgery, all proteins accumulate in the lumbar CSF. Conclusion: For brain-derived proteins, we could not confirm a rostrocaudal CSF gradient while lepto-meningeal and blood-derived proteins accumulate in the lumbar CSF. We conclude that for the interpretation of protein CSF concentrations, the source of the sample is of crucial importance.
© 2013 S. Karger AG, Basel
Related Articles:
References
- Ottens AK, Kobeissy FH, Golden EC, Zhang Z, Haskins WE, Chen SS, et al: Neuroproteomics in neurotrauma. Mass Spectrom Rev 2006;25:380-408.
- Biberthaler P, Mussack T, Wiedemann E, Kanz KG, Koelsch M, Gippner-Steppert C, et al: Evaluation of S100B as a specific marker for neuronal damage due to minor head trauma. World J Surg 2001;25:93-97.
- Rothermundt M, Peters M, Prehn JH, Arolt V: S100B in brain damage and neurodegeneration. Microsc Res Tech 2003;60:614-632.
- Reiber H: Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 2001;310:173-186.
- Kleindienst A, Meissner S, Eyupoglu IY, Parsch H, Schmidt C, Buchfelder M: Dynamics of S100B release into serum and cerebrospinal fluid following acute brain injury. Acta Neurochir Suppl 2010;106:247-250.
- Persson L, Hardemark H, Edner G, Ronne E, Mendel-Hartvig I, Pahlman S: S-100 protein in cerebrospinal fluid of patients with subarachnoid haemorrhage: a potential marker of brain damage. Acta Neurochir (Wien) 1988;93:116-122.
- Woertgen C, Albert R, Kohler M, Rzepecki A, Rothoerl RD, Bein T, et al: Ventricular tapping seems to have no influence on S-100B and NSE serum concentrations. Neurosurg Rev 2004;27:178-180.
- Takayasu M, Shibuya M, Kanamori M, Suzuki Y, Ogura K, Kageyama N, et al: S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 1985;63:417-420.
- Bloomfield SM, McKinney J, Smith L, Brisman J: Reliability of S100B in predicting severity of central nervous system injury. Neurocrit Care 2007;6:121-138.
- Petzold A, Keir G, Lim D, Smith M, Thompson EJ: Cerebrospinal fluid and serum S100B: release and wash-out pattern. Brain Res Bull 2003;61:281-285.
- Kleine TO, Benes L, Zofel P: Studies of the brain specificity of S100B and neuron-specific enolase in blood serum of acute care patients. Brain Res Bull 2003;61:265-279.
- Hayakata T, Shiozaki T, Tasaki O, Ikegawa H, Inoue Y, Toshiyuki F, et al: Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004;22:102-107.
- Shore PM, Thomas NJ, Clark RS, Adelson PD, Wisniewski SR, Janesko KL, et al: Continuous versus intermittent cerebrospinal fluid drainage after severe traumatic brain injury in children: effect on biochemical markers. J Neurotrauma 2004;21:1113-1122.
- Nygaard O, Langbakk B, Romner B: Age- and sex-related changes of S-100 protein concentrations in cerebrospinal fluid and serum in patients with no previous history of neurological disorder. Clin Chem 1997;43:541-543.
- Kleindienst A, Schmidt C, Parsch H, Emtmann I, Xu Y, Buchfelder M: The passage of S100B from brain to blood is not specifically related to the blood-brain barrier integrity. Cardiovasc Psychiatry Neurol 2010;2010:801295.
- Reiber H, Peter JB: Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 2001;184:101-122.
- Missler U, Wiesmann M, Friedrich C, Kaps M: S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke. Stroke 1997;28:1956-1960.
- Jacobi C, Reiber H: Clinical relevance of increased neuron-specific enolase concentration in cerebrospinal fluid. Clin Chim Acta 1988;177:49-54.
- Hoffmann A, Conradt HS, Gross G, Nimtz M, Lottspeich F, Wurster U: Purification and chemical characterization of β-trace protein from human cerebrospinal fluid: its identification as prostaglandin D synthase. J Neurochem 1993;61:451-456.
- Urade Y, Kitahama K, Ohishi H, Kaneko T, Mizuno N, Hayaishi O: Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci USA 1993;90:9070-9074.
- Reiber H, Walther K, Althaus H: Beta-trace protein as sensitive marker for CSF rhinorhea and CSF otorhea. Acta Neurol Scand 2003;108:359-362.
- Staykov D, Huttner HB, Struffert T, Ganslandt O, Doerfler A, Schwab S, et al: Intraventricular fibrinolysis and lumbar drainage for ventricular hemorrhage. Stroke 2009;40:3275-3280.
- Van Engelen BG, Lamers KJ, Gabreels FJ, Wevers RA, van Geel WJ, Borm GF: Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. Clin Chem 1992;38:813-816.
- Tarnaris A, Toma AK, Chapman MD, Petzold A, Keir G, Kitchen ND, et al: Rostrocaudal dynamics of CSF biomarkers. Neurochem Res 2011;36:528-532.
- Brandner S, Thaler C, Buchfelder M, Kleindienst A: Brain-derived protein concentrations in the cerebrospinal fluid: contribution of trauma from ventricular drain insertion. J Neurotrauma 2013;30:1205-1210.
Article / Publication Details
Received: March 27, 2013
Accepted: May 05, 2013
Published online: August 17, 2013
Issue release date: October 2013
Number of Print Pages: 6
Number of Figures: 2
Number of Tables: 1
ISSN: 0014-3022 (Print)
eISSN: 1421-9913 (Online)
For additional information: https://www.karger.com/ENE
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
